Premium
CIRCUMCISION AND/OR VACCINATION AGAINST HUMAN PAPILLOMAVIRUS IN THE MALE TO PREVENT INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS: AN EARLY SURROGATE ENDPOINT FOR THE LATER PREVENTION OF PENILE, PROSTATE, ANAL AND ORAL CANCER?
Author(s) -
Oliver R.T.D.
Publication year - 2009
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2009.08596.x
Subject(s) - medicine , human papillomavirus , penile cancer , human immunodeficiency virus (hiv) , prostate cancer , male circumcision , vaccination , anal cancer , surrogate endpoint , clinical endpoint , cancer , virology , clinical trial , population , environmental health , health services